Ask the Expert: What Is the Significance of IGHV Mutation Status?


In this “Ask the Expert” segment, a patient asks,  “What is the significance of the IGHV mutation status?  When should newly diagnosed CLL patients get this test?” CLL expert Dr. Jeff Sharman, Medical Director of Hematology Research at US Oncology Network, discusses IGHV and its role in predicting CLL prognosis and disease progression. 

Sponsored through an educational grant from the Patient Empowerment Network, which received support from AbbVie Inc. and Genentech Inc.

Sign in or Register to view comments.